Uncategorized
Aerie Pharmaceuticals to Present at Two Investor Conferences in June
IRVINE, Calif.--(BUSINESS WIRE)--Aerie Pharmaceuticals, Inc. (Nasdaq: AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of glaucoma and other diseases of the eye, today announced that Vicente Anido, Jr., Ph.D., Chairman and Chief Executive Officer, and Richard Rubino, Chief Financial Officer, will attend the following conferences in June. Jefferies 2017 Healthcare Conference Presentation Date: